TORONTO, July 16, 2019 /CNW Telbec/ - Anova Fertility & Reproductive Health Inc. ("Anova") is pleased to welcome William ("Bill") Hughson as Chair of the Anova Board of Directors.
Following Anova's recent partnership with Persistence Capital Partners ("PCP"), a private equity fund focused exclusively on investing in high-growth opportunities in Canadian healthcare, Anova is poised to execute on a number of strategic initiatives focused on increasing access for its clients through expansion and growth. These initiatives include opening new clinics, pursuing investment and partnership opportunities, creating a collaborative and 'cutting edge' environment for physicians and other healthcare practitioners, and investing in the best global technologies and techniques to help Canadians grow their families.
Founded by Dr. Marjorie Dixon, Chief Executive Officer, Anova boasts a state-of-the-art embryology laboratory and a clinic inspired by Dr. Dixon's desire to combine the best global technologies and techniques to elevate the patient experience, improve patient outcomes and humanize treatment in fertility care.
"At Anova we strive to elevate the patient experience by creating a supportive and caring environment," added Dr. Dixon. "As Anova expands operations we will benefit from Bill's deep experience supporting our science, patient care, and business strategy as we scale our organization, and I look forward to working closely with Bill as we implement the shared vison."
Adrianna Czornyj, Partner at PCP, said, "Bill has extensive experience leading growth strategies in the healthcare industry and has extensive knowledge and expertise in both the Canadian and US fertility space. Adding Bill to the Board as an independent director is part of accelerating Anova's strategic growth plans."
"Anova is a leading provider of reproductive health services in Canada and abroad, using best-in-class techniques from around the world. Today, I am proud to join the Board of Directors and look forward to being a part of this amazing organization; helping Anova to achieve its objectives, but more importantly contributing to the growth of families with Anova's patient-centric fertility care," said Bill.
Mr. Hughson has extensive executive and healthcare experience, having most recently served as Chief Executive Officer of Blue Sky Vision ("BSV"). BSV is dedicated to providing world-class support to leading providers of eye care services. Prior to BSV, Bill served as President, Chief Executive Officer and Vice Chairman of IntegraMed Fertility, the largest network of fertility practices in North America.
About Anova Fertility & Reproductive Health Inc.
Anova Fertility & Reproductive Health Inc. opened in 2016 as a full-service fertility and IVF clinic. Anova is Canada's first next-generation embryology laboratory, and is the leader in innovation, education, and communication for high quality patient centric fertility and reproductive care. The team at Anova strives to set the international standard for successful reproductive health and fertility centres, committed to making the right to family accessible to everyone. Anova is known for their culture of support, effective processes and their holistic approach to patient care. For more information about Anova, please visit www.anovafertility.com.
About Persistence Capital Partners
Persistence Capital Partners is Canada's leading private equity fund exclusively focused on high-growth opportunities in the healthcare field. With deep healthcare industry expertise, PCP aims to create significant long-term capital appreciation for its investors by identifying and developing attractive investment opportunities in the Canadian healthcare market. PCP has offices in Montreal, Quebec, and Toronto, Ontario. For more information about Persistence Capital Partners, please visit www.persistencecapital.com.
SOURCE Persistence Capital Partners
Dr. Marjorie Dixon, Founder, Medical Director, and Chief Executive Officer, Anova Fertility & Reproductive Health Inc., E: [email protected]; Adrianna Czornyj, Partner, Persistence Capital Partners, E: [email protected]
Share this article